Unique Clinical Pearl sessions are held throughout the AAPP Annual Meeting. Slide sets for these sessions are made available through the AAPP Communities.
2026 Annual Meeting
- Bye K. Lithium toxicity following GLP-1 RA Initiation: An Emerging Drug-Drug Interaction [Weblink]
- Rovelo M. What to Expect When You’re Not Expecting: a Review of Pseudocyesis [Weblink]
- Harrison M. Management of Clozapine-Induced Obsessive Compulsive Symptoms [Weblink]
2025 Annual Meeting
- Dickinson J. Pseudoephedrine for Clozapine-Induced Nocturnal Enuresis [Weblink]
- Ehrhard K. Delirious Mania: Navigating Identification, Treatment, and Diagnostic Limbo [Weblink]
- Karavolis, Z. Monitoring Methadone: Beyond the EKG [Weblink]
- Mosley B. Aripiprazole Loading Strategy for Acute Mania [Weblink]
- Sabol, R. Pee Attention!: Interpreting Fentanyl Urine Drug Tests [Weblink]
- Scalise, A. The Role of Buprenorphine in Restless Legs Syndrome [Weblink]
2024 Annual Meeting
- Abelleira A. Home Sweet Home: Operationalizing Low-Dose Buprenorphine Initiations for Virtual Care. [Weblink]
- Allen S. Paternal Postpartum Depression – Identification and Barriers. [Weblink]
- Crouse E. For the First Time in Forever: There’s a New Drug-Drug Interaction with Lithium. [Weblink]
- Maister A. The “Other Booster”: Clozapine Augmentation with Fluvoxamine. [Weblink]
- Mustafa A. Tackling the Treatment of Tardive Dyskinesia. [Weblink]
- Rarrick C. Pearls for Creating a Collaborative Practice Agreement. [Weblink]
Reviewer 1: Christine Sun, PharmD, BCPP
Reviewer 2: Austin Smith, PharmD, BCPP
2026-2027 AAPP Resident and New Practitioner Committee